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Abstract
I In nt tr ro od du uc ct ti io on n: : This  study  investigated  the  prevalence  of  transthoracic
echocardiographic  abnormalities  in  patients  with  ischemic  stroke  (IS),
subarachnoid hemorrhage (SAH), and intracerebral hemorrhage (ICH) in sinus
rhythm.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   The patients included 120 with IS, 30 with SAH, and 
41 with ICH. All diagnoses were confirmed by magnetic resonance imaging or
brain computed tomography. Two-dimensional echocardiograms were taken at
the time stroke was diagnosed. All echocardiograms were interpreted by an
experienced echocardiographer.
R Re es su ul lt ts s: :   Of 120 IS patients, 1 (1%) had a left ventricular (LV) thrombus, 1 (1%)
had mitral valve vegetations, 30 (25%) had LV hypertrophy, 26 (22%) had
abnormal LV ejection fraction, 4 (3%) had mitral valve prolapse, 33 (28%) had
mitral annular calcium (MAC), 40 (33%) had aortic valve calcium (AVC), 3 (3%)
had a bioprosthetic aortic valve, 10 (8%) had aortic stenosis (AS), 6 (5%) had
atrial septal aneurysm, 2 (2%) had patent foramen ovale, and 40 (33%) had no
abnormalities. Of 30 SAH patients, 5 (17%) had LV hypertrophy, 1 (3%) had
abnormal LV ejection fraction, 1 (3%) had AS, 4 (13%) had MAC, 5 (17%) had AVC,
and 20 (67%) had no abnormalities. Of 41 ICH patients, 9 (22%) had LVH, 1 (2%)
had abnormal LV ejection fraction, 1 (3%) had AS, 6 (15%) had MAC, 8 (20%) had
AVC, and 22 (54%) had no abnormalities.
C Co on nc cl lu us si io on ns s: :   Transthoracic echocardiographic abnormalities are more prevalent
in patients with IS than in patients with SAH or ICH.
K Ke ey y    w wo or rd ds s: :    echocardiography,  ischemic  stroke,  subarachnoid  hemorrhage,
intracerebral hemorrhage.
Introduction
Transthoracic 2-dimensional echocardiography (TTE) has been used in
the diagnosis and management of ischemic stroke (IS) with conflicting
data as whether it should be considered an essential test in all IS patients
in sinus rhythm [1-5]. Few data are published on TTE in patients with
subarachnoid hemorrhage (SAH) [6].
We reported the prevalence of electrocardio-graphic abnormalities in
patients with IS, SAH, and intrcerebral hemorrhage (ICH) [7]. Of these
patients, 120 with IS, 30 with SAH, and 41 with ICH who were in sinus
rhythm had Doppler echocardiograms and 2-dimensional echocardiograms
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performed trans-thoracically at the time stroke was
diagnosed.  The  present  article  reports  the
prevalence of TTE abnormalities diagnosed at the
time IS, SAH, and ICH were diagnosed.
Material and methods
The  patients  included  120  (64  men  and 
56  women),  mean  age  67  ±11  years,  with  IS, 
30 (14 men and 16 women), mean age 51 ±10 years,
with SAH, and 41 (23 men and 18 women), mean age
61 ±10 years, with ICH hospitalized at Westchester
Medical Center/New York Medical College. This was
the first episode of IS, SAH, or ICH for each of the
patients. All diagnoses were made by aboard certified
neurologist and confirmed by magnetic resonance
imaging or brain computed tomography. Patients with
chest  pain  or  a diagnosis  of  acute  myocardial
infarction were excluded from the study. All patients
were in sinus rhythm at the time of stroke.
Doppler echocardiograms and 2-dimensional
echocardiograms were performed transthoracically
at the time stroke was diagnosed. All echocar-
diograms  were  interpreted  by  a cardiologist
experienced in interpreting echocardiograms.
The left ventricular (LV) ejection fraction was
diagnosed as abnormal if it was less than 50% [8]. LV
hypertrophy was diagnosed if the LV mass index
exceeded 134 g/m2in men and 110 g/m2in women [9]. 
Student’s t tests  were  used  to  diagnose
continuous variables. Chi-square tests were used
to analyze dichotomous variables.
Results
The patients with IS were significantly older than
the  patients  with  SAH  (p <  0.001)  and  ICH 
(p < 0.002). The patients with ICH were significantly
older than the patients with SAH (p < 0.001).
Table  I shows  the  prevalence  of  echocar-
diographic abnormalities in the patients with IS,
SAH, and ICH. Echocardiographic abnormalities were
present in 67% of patients with IS, in 46% of
patients with ICH, and in 33% of patients with SAH
(p < 0.001 comparing IS with SAH and p < 0.025
comparing IS with ICH). An abnormal LV ejection
fraction was present in 22% of patients with IS, in
3% of patients with SAH, and in 2% of patients with
ICH (p < 0.01 comparing IS with ICH and p < 0.02
comparing IS with SAH). 
Of 120 patients with IS, 14 (12%) had in-hospital
mortality  and  106  (88%)  had  nonfatal  IS.  Of 
30 patients with SAH, 5 (17%) had in-hospital
mortality, and 25 (83%) had nonfatal SAH. Of 
41 patients with ICH, 11 (27%) had in-hospital
mortality and 30 (73%) had nonfatal ICH.
Discussion
Beattie  et  al. [1]  reported  that  the  mean
prevalence of echocardiographic abnormalities in
the  medical  literature  for  patients  older  than 
45 years presenting with IS or transient ishemic
attack was 0.1% for myxoma, 1.0% for vegetations,
2.0% for mitral stenosis, 0.3% for left atrial thrombi,
T Ta ab bl le e   I I. . Prevalence of echocardiographic abnor-malities in patients with ischemic stroke, subarachnoid hemorrhage,
and intracerebral hemorrhage in sinus rhythm
LV – left ventricular
V Va ar ri ia ab bl le e I Is sc ch he em mi ic c S Su ub ba ar ra ac ch hn no oi id d I In nt tr ra ac ce er re eb br ra al l
s st tr ro ok ke e   ( (n n = =   1 12 20 0) ) h he em mo or rr rh ha ag ge e   ( (n n = =   3 30 0) ) h hm mo or rr rh ha ag ge e   ( (n n = =   4 41 1) )
Abnormal LV ejection fraction  26 (22%) 1 (3%) 1 (2%)
LV hypertrophy 30 (25%) 5 (17%) 9 (22%)
LV thrombus  1 (1%) 0 (0%) 0 (0%)
Mitral valve vegetations 1 (1%) 0 (0%) 0 (0%)
Mitral valve prolapse 4 (3%) 0 (0%) 0 (0%)
Mitral annular calcium 33 (28%) 4 (13%) 6 (15%)
Bioprosthetic aortic valve 3 (3%) 0 (0%) 0 (0%)
Aortic stenosis 10 (8%) 1 (3%) 1 (2%)
Aortic valve calcium 40 (33%) 5 (17%) 8 (20%)
Atrial septal aneurysm 6 (5%) 0 (0%) 0 (0%)
Patent foramen ovale  2 (2%) 0 (0%) 0 (0%)
LV enlargement 12 (10%) 1 (3%) 1 (2%)
Left atrial enlargement 26 (22%) 4 (13%) 6 (15%)
Mitral regurgitation  35 (29%) 4 (13%) 6 (15%)
Aortic regurgitation 26 (22%) 4 (13%) 6 (15%)
Normal echocardiogram 40 (33%) 20 (67%) 22 (54%)
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10.0% for cardiomyopathy, 9.0% for LV thrombi/
patent foramen ovale/atrial septal defect, and 3.0%
for atrial septal aneurysm. An abnormal LV ejection
fraction was present in 5 of 47 patients (11%) with
SAH [6].
In the present study, an abnormal LV ejection
fraction was present in 22% of patients with IS, in
3% of patients with SAH, and in 2% of patients with
ICH (p < 0.01 comparing IS with ICH and p < 0.02
comparing IS with SAH). LV thrombus was present
in 1% of patients with IS. Mitral valve vegetations
were present in 1% of patients with ischemic stroke.
Atrial  septal  aneurysm  was  present  in  5%  of
patients with IS. A patent foramen ovale was
present in 2% of patients with IS.
Mitral valve prolapse was present in 2% of
patients with IS [2, 3] and in 3% of IS patients in
the present study. A bioprosthetic valve was present
in 2% of 95 patients with IS [2] and in 3% of
patients with IS in the present study. Aortic stenosis
was present in 3% of patients with IS [3] and in 8%
of patients with IS, 3% of patients with ICH, and in
2% of patients with SAH in the present study. Aortic
valve thickening was present in 35% of 95 patients
with IS [2]. Aortic valve calcium was present in 33%
of patients with IS, in 17% of patients with ICH, and
in 20% of patients with SAH in the present study.
LV hypertrophy is a major risk factor for IS [9-11]
and was present in 25% of patients with IS, 17% of
patients with SAH, and 22% of patients with ICH in
the present study. Mitral annular calcium is also
a risk factor for stroke [12-14] and was present in
14% of 95 patients with IS [2]. In the present study,
mitral annular calcium was present in 28% of
patients with IS, 13% of patients with ICH, and in
15% of patients with SAH.
Data on the prevalence of an enlarged left
atrium,  an  enlarged  left  ventricle,  mitral
regurgitation, and aortic regurgitation in patients
with IS, ICH, and SAH are not published but are
presented in the present study in Table I.
Although there are conflicting data about the
usefulness of TTE in the diagnosis and therapy of
IS in patients with sinus rhythm [1-5], data from the
present study support its use in patients in whom
the etiology of stroke is unclear. In the present
study,  echocardiographic  abnormalities  were
diagnosed in 67% of patients with IS, 33% of
patients with SAH, and in 46% of patients with ICH.
To the best of our knowledge, this study is the only
series of patients showing the prevalence of all
echocardiographic abnormalities in patents with IS,
SAH, and ICH.
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